Evolve Med Spa is offering 20% off all services and products for nurses and has contributed donations to local healthcare systems in honor of Nurse’s Week.
Evolve Med Spa in Hoboken
All Evolve Med Spa clinics will be participating in honoring nurses for Nurse’s Week with discounts, raffles and giveaways.
RED BANK, N.J., May 10, 2023 (Newswire.com)
Evolve Med Spa, an award-winning destination for skin rejuvenation, body contouring and injectable treatments, is proud to announce that it will be offering nurses 20% off all services and treatments for the month of May in honor of Nurse’s Week.
In addition to the discount, Evolve Med Spa has also donated over $5,000 in products and services to local heathcare systems, hospitals, medical practices, and urgent care centers.
“Nurses are the backbone of our community’s physical and mental health, and we are so grateful for their dedication and hard work,” said Dr. Osbert Fernandez, Medical Director and co-founder of Evolve Med Spa. “We want to show our appreciation for all that they do and honor the impact they make every single day.”
The 20% discount is available to all nurses who present their nursing license or ID card at the time of service. The discount is valid for all services and treatments offered at Evolve Med Spa, including:
- Botox, Dysport, Jeuveau and Xeomin
- Laser hair removal
- Chemical peels
- Body sculpting
- Retail skincare products
- All other services
The discount is valid for the month of May 2023. To schedule an appointment, book online at: evolvemedspa.com
About Evolve Med Spa
Evolve Med Spa is a leading provider of medical spa services with locations throughout New Jersey, New York and Maryland. Evolve Med Spa helps you look your best, feel confident, and be unapologetically you. Our highly trained, physician-led team of medical and aesthetic professionals customizes treatments for you based on proven technology and an artist’s eye for natural beauty, leaving you confident, empowered, and positively glowing.
VP, Brand and Client Experience
Evolve Med Spa Announces Celebration of Nurse’s Week
The post Evolve Med Spa Announces Celebration of Nurse’s Week first appeared on NT Beauty.
Cupshe x Vanessa Morgan; The River Collection is available for early access exclusively on Cupshe.com
Cupshe x Vanessa Morgan
The post Vanessa Morgan Partners With Cupshe for an Exclusive Mommy and Me Swimwear Collection first appeared on RSVTV news.
Gossip Stone TV is thrilled to announce that Michele Guzy will be joining the jury in the upcoming season of Hypno Challenge, the hit reality show that puts contestants’ hypnotic abilities to the test. Guzy, an internationally known hypnotherapist, life coach, and motivational speaker, is regarded as one of the top hypnotherapists in Los Angeles […]
The post Gossip Stone TV Announces Michele Guzy as Jury in Hypno Challenge Reality Show first appeared on RSVTV news.
FarmaKeio Outsourcing is proud to announce the release of its latest innovation, the only patented hormone pellet with triamcinolone developed in an FDA-registered 503B outsourcing facility. The pellet is set to provide a new and revolutionary solution to hormone replacement therapy for men and women.
The patented hormone pellet formulated with an anti-inflammatory for better outcomes.
FarmaKeio Outsourcing’s patented pellet is developed in an FDA-registered 503B facility and distinctly designed to deliver a more comfortable treatment option to patients.
SOUTHLAKE, Texas, May 10, 2023 (Newswire.com)
FarmaKeio Outsourcing (FKO), a leading pharmaceutical outsourcing facility in the United States, has been granted a patent to produce testosterone and triamcinolone subcutaneous hormone pellets. The patent includes 23 claims, issued by the United States Patent and Trademark Office (USPTO), recognizing the company’s innovative approach to compounding hormone therapy and solidifying its position as a leader in the field of pharmaceutical development.
Unlike other hormone therapies, which may require frequent injections or daily pills, FarmaKeio Outsourcing’s hormone pellets provide a sustained release of testosterone and triamcinolone, allowing patients to enjoy the benefits of these hormones for extended periods of time. These pellets are inserted subcutaneously and gradually release the hormone over several months, reducing the need for frequent dosing and allowing patients to focus on their daily lives.
“We are thrilled to receive this patent for our subcutaneous hormone pellets,” said FarmaKeio Outsourcing’s CEO, Dan DeNeui. “Our team has worked tirelessly to develop this innovative approach to hormone therapy, and we are excited to be able to offer this option to patients in need.”
In addition to providing a more convenient method of hormone therapy, FarmaKeio’s pellets offer a unique formulation that is not available from any other FDA 503B registered outsourcing facility in the US. This proprietary formulation has been carefully designed and tested and it represents a significant breakthrough in the field of hormone therapy.
“We believe that our hormone pellets have the potential to revolutionize the way that hormone therapy is delivered,” said DeNeui. “By offering a sustained release of testosterone and triamcinolone, we can provide patients with a more consistent and reliable treatment option that can improve their quality of life.”
The issuance of this patent is a significant milestone for FarmaKeio Outsourcing, and it reflects the company’s ongoing commitment to innovation and excellence in pharmaceutical development. As the demand for hormone therapy continues to grow, FarmaKeio is well-positioned to meet the needs of patients and healthcare providers alike with its cutting-edge hormone pellets.
“We are confident that our hormone pellets will become the gold standard for hormone therapy, and we look forward to working with healthcare providers and patients to make this technology available to as many people as possible,” said Chief Operating Officer Cody Boatman.
The hormone pellet with triamcinolone is a groundbreaking new product that is set to revolutionize the hormone replacement therapy industry. With its unique combination of hormones and anti-inflammatory properties, it provides patients with a more comfortable treatment option. The pellet is an exclusive feature of The EvexiPEL Method, created and founded by Terri DeNeui, DNP, APRN, ACNP-BC, and is available exclusively through FarmaKeio Outsourcing, an FDA-registered 503B facility. With this new product, FarmaKeio Outsourcing is once again proving its commitment to providing innovative solutions to hormone replacement therapy.
About FarmaKeio Outsourcing
FarmaKeio Outsourcing is a leading FDA-registered 503B pharmaceutical outsourcing facility that specializes in providing specific custom compounded medications to healthcare providers and facilities across the United States. FarmaKeio Outsourcing is committed to providing innovative, patient-centered solutions that meet the unique needs of their clients.
FarmaKeio Outsourcing offers an unwavering commitment to quality, safety, and compliance, operating a state-of-the-art facility that is cGMP compliant and undergoes rigorous testing and quality assurance procedures to ensure the highest level of quality and safety.
FarmaKeio Outsourcing provides exceptional customer service and support, ensuring that their clients have access to the resources and expertise necessary to make informed decisions about patient care. FarmaKeio Outsourcing is a trusted partner for healthcare providers looking to offer the most innovative and advanced care solutions to their patients.
Director of Marketing
collaboratehealth® partners with MedBridge Healthcare to provide sleep apnea screening, diagnosis and therapy monitoring through their current technology platform.
Leading B2C Incontinence Care Brand Comes Together With Trusted Senior Advisory Service to Help Families Better Manage Incontinence Care
The leader in online ADHD assessment and diagnosis released a month-long special series focused on raising awareness by sharing the stories of people living with ADHD.
The podcast series was created to raise awareness for ADHD by sharing the personal stories of people who have ADHD, with a different person’s story released every day throughout the month of October for ADHD Awareness Month. ADHD Online received the “Award of Excellence” for the series in the following categories: “Cause and Awareness” and “Diversity, Equity, and Inclusion”. Refocused, Together was also recognized with an “Award of Distinction” for Educational series.
“You always hope your work matters, so to have Refocused recognized by our peers before we’ve even hit our one-year anniversary is an incredible accomplishment and one I’m very proud of,” podcast host and producer Lindsay Guentzel said. “Refocused, Together was without a doubt the most challenging project I’ve ever worked on and I can’t wait to continue the legacy this October by sharing another 31 stories, one every day throughout the entire month of ADHD Awareness Month.”
Keith Boswell, ADHD Online’s vice president of marketing, said, “The collaboration on the podcast with Lindsay has been more successful than we could have hoped for. We wanted to share something with our patients and others that would be valuable, informative, and relatable. That’s what Lindsay does so well, and it’s why Refocused, Together is being recognized. We’re so proud of this partnership.”
The Communicator Awards is dedicated to recognizing excellence, effectiveness, and innovation across all areas of communication. They are the leading international awards program honoring talent in this highly competitive field. Founded nearly three decades ago, The Communicator Awards receives almost 5,000 entries from companies, agencies, studios, and boutique shops of all sizes, making it one of the largest award shows of its kind worldwide.
For its 29th season, the awards aimed to bring clear and impactful storytelling to the forefront, with an expanded representation of categories in Corporate Communications, Public Relations, and Integrated Marketing. All the categories can be found under a completely new and more intuitive framework.
About ADHD Online
ADHD Online was founded in 2018 with the mission that everyone should have access to quality ADHD assessments regardless of who and where they reside. The ADHD Online team is filled with industry experts across the United States all sharing the same passion for ADHD and making sure patients have access to critical mental health services. ADHD Online is leading the way with being a critical voice for those who might be struggling with ADHD and is the only organization to offer HIPAA-secured ADHD assessments online with results from licensed psychologists. ADHD Online is active in all 50 states.